Omega Therapeutics, Inc.
OMGA
Revenue
2.61M
▲478.00k▲22.40%
3 Months ChangeAssets
152.73M
▼-15.50M▼-9.21%
3 Months ChangeLiabilities
141.18M
▼-779.00k▼-0.5487%
3 Months ChangeFree Cash Flow
-12.34M
▲11.16M▲47.49%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112962
2024-08-30
Form 8-K
ID: 0000950170-24-102313
2024-08-06
Form 10-Q
ID: 0000950170-24-091197
2024-08-06
Form 8-K
ID: 0000950170-24-091196
2024-06-24
Form 8-K
ID: 0000950170-24-076685
2024-05-30
Form 8-K
ID: 0000950170-24-066746
2024-05-06
Form 10-Q
ID: 0000950170-24-053198
2024-05-06
Form 8-K
ID: 0000950170-24-053194
2024-04-16
Form 8-K
ID: 0000950170-24-044795
2024-03-28
Form 8-K
ID: 0000950170-24-038053